文献速递角膜与眼表疾病眼外伤

角膜移植术后真菌感染及保存液抗真菌补充的作用

Fungal infection after keratoplasty and the role of antifungal supplementation to storage solution: a review.
PubMed 文献 · Br J Ophthalmol · 2019-12-03

该综述关注角膜移植术后真菌感染,指出美国眼库报告移植后真菌感染率呈上升趋势且真菌感染占比反超细菌感染,供体角巩膜缘真菌培养阳性与术后感染高度相关。美国眼库广泛使用的Optisol GS保存液目前不含抗真菌补充剂,虽缺乏大型随机对照试验,但多项研究评估了抗真菌剂减少供体角膜真菌污染且不引起过度角膜毒性的作用。

要点

  • 角膜移植术后真菌感染虽罕见但具破坏性,美国眼库报告其发生率呈上升趋势。
  • 供体角巩膜缘真菌培养阳性与术后感染高度相关,支持常规行缘部真菌培养。
  • Optisol GS保存液不含抗真菌补充剂,其常规补充的安全性和有效性尚缺大型随机对照试验。

核心结论

  • 角膜移植术后真菌感染发生率呈上升趋势,真菌已反超细菌成为术后感染的重要病原,需关注供体缘真菌培养与保存液抗真菌补充策略。

研究设计与样本

  • 本文为综述,汇总角膜移植术后真菌感染的流行病学证据及保存液抗真菌补充的研究证据。

主要发现

  • 美国眼库协会报告移植后真菌感染率呈上升趋势,且逆转了既往细菌感染占多数的格局。
  • 多项研究证实供体角巩膜缘真菌培养阳性与术后感染高度相关。
  • Optisol GS是美国眼库最广泛使用的角膜保存液,目前不含任何抗真菌补充剂。
  • 多项研究评估了抗真菌剂减少供体角膜真菌污染且不引起过度角膜毒性的作用,但缺乏大型随机对照试验。

临床怎么用

  • 临床应重视角膜移植术后真菌感染的上升趋势,并考虑对供体常规行角巩膜缘真菌培养。
  • 在缺乏大型随机对照试验证据的情况下,保存液抗真菌补充的常规应用需权衡减少真菌污染与角膜毒性。

局限性

  • 评估常规抗真菌补充保存液有效性及安全性的大型随机对照试验尚缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fungal infection after corneal transplantation is a rare, yet potentially devastating, postoperative complication and has become a growing concern for the transplant surgeon and eye banking community. The Eye Bank Association of America (EBAA) has reported an increasing trend in the rate of postkeratoplasty fungal infections and a reversal in the previously documented predominance of bacterial over fungal infections. Additionally, several studies have confirmed a high correlation between positive corneoscleral donor rim fungal cultures and postoperative infections. Optisol GS (Bausch & Lomb, Irvine, California, USA), the most extensively used corneal storage solution in US eye banks, does not currently contain any antifungal supplementation. Although large randomised control trials evaluating the efficacy and safety of routine antifungal supplementation to corneal storage solution are lacking, several investigative studies have assessed the role of antifungal agents in reducing fungal contamination of donor corneas without causing undue corneal toxicity. This review will present the current epidemiology of postkeratoplasty fungal infections and evidence for obtaining routine fungal rim cultures and antifungal supplementation of storage solution.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Thareja T, Kowalski R, Kamyar R, et al. Fungal infection after keratoplasty and the role of antifungal supplementation to storage solution: a review. Br J Ophthalmol. 2019. PMID: 31796428. doi:10.1136/bjophthalmol-2019-314664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。